BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 4542440)

  • 1. Immunotherapy for melanoma.
    Vaisrub S
    JAMA; 1973 Sep; 225(10):1242. PubMed ID: 4542440
    [No Abstract]   [Full Text] [Related]  

  • 2. Non-specific and specific immunotherapy in patients with melanoma.
    Seigler HF; Shingleton WW; Metzgar RS; Buckley CE; Bergoc PM; Miller DS; Fetter BF; Phaup MB
    Surgery; 1972 Jul; 72(1):162-74. PubMed ID: 4555924
    [No Abstract]   [Full Text] [Related]  

  • 3. Delayed cutaneous sensitivity reactions to extracts of autologous malignant melanoma: a second look.
    Bluming AZ; Vogel CL; Ziegler JL; Kiryabwire JW
    J Natl Cancer Inst; 1972 Jan; 48(1):17-24. PubMed ID: 4652371
    [No Abstract]   [Full Text] [Related]  

  • 4. [The characterization of tumour-associated membrane-bound antigens and their implementation in the treatment of malignant melanoma (author's transl)].
    Kokoschka EM
    Wien Klin Wochenschr Suppl; 1979; 97():3-32. PubMed ID: 106559
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunology and cutaneous malignant melanoma.
    Sober AJ
    Int J Dermatol; 1976; 15(1):1-18. PubMed ID: 1107238
    [No Abstract]   [Full Text] [Related]  

  • 6. Viral oncolysate in the management of malignant melanoma. I. Preparation of the oncolysate and measurement of immunologic responses.
    Cassel WA; Murray DR; Torbin AH; Olkowski ZL; Moore ME
    Cancer; 1977 Aug; 40(2):672-9. PubMed ID: 196739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunology of human malignant melanoma.
    Lewis MG
    Ser Haematol; 1972; 5(5):44-65. PubMed ID: 4598040
    [No Abstract]   [Full Text] [Related]  

  • 8. [Immunological reactions of skin melanoma patients to nonspecific and adaptive immunotherapy].
    Trapeznikov NN; Iavorskiĭ VV; Kadagidze ZG; Malaev SG; Kupin VI
    Vopr Onkol; 1977; 23(8):27-33. PubMed ID: 906404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Immunotherapy].
    Lejeune FJ; Bernheim JL; Vanwijck R
    Acta Chir Belg; 1974 Mar; 73(2):265-93. PubMed ID: 4450923
    [No Abstract]   [Full Text] [Related]  

  • 10. Potentiation and arming of lymphocyte mediated immunity by sera from melanoma patients.
    Vanwijck R; Bouillenne C; Malek-Mansour S
    Eur J Cancer (1965); 1975 Apr; 11(4):267-76. PubMed ID: 1079770
    [No Abstract]   [Full Text] [Related]  

  • 11. The immunobiology of human malignant melanoma.
    Bystryn JC
    Int J Dermatol; 1980 Sep; 19(7):375-8. PubMed ID: 6998878
    [No Abstract]   [Full Text] [Related]  

  • 12. [Immunological aspects in malignant melanoma].
    Macher E
    Arch Dermatol Forsch; 1972; 244():234-9. PubMed ID: 4675197
    [No Abstract]   [Full Text] [Related]  

  • 13. [Cutaneous, cellular immunity in malignant melanoma].
    Kehrer HC
    Wien Klin Wochenschr; 1991; 103(13):396-7. PubMed ID: 1897233
    [No Abstract]   [Full Text] [Related]  

  • 14. [Immunology of malignant melanoma].
    Misgeld V
    Hautarzt; 1973 Dec; 24(12):511-9. PubMed ID: 4599321
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunotherapeutic approaches to the management of neoplasms.
    Klein E; Holtermann OA
    Natl Cancer Inst Monogr; 1972 Dec; 35():379-402. PubMed ID: 4572833
    [No Abstract]   [Full Text] [Related]  

  • 16. The therapy of malignant melanoma with transfer factor. A preliminary report.
    Price FB; Hewlett JS; Deodhar SD; Barna B
    Cleve Clin Q; 1974; 41(1):1-4. PubMed ID: 4545020
    [No Abstract]   [Full Text] [Related]  

  • 17. Some aspects of cell-mediated hypersensitivity in patients with melanoma.
    Moszkowska G; Jassem J; Kondrat W; Kopacz A; Goszczyńska E
    Arch Immunol Ther Exp (Warsz); 1980; 28(4):655-60. PubMed ID: 6970028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Melanoma-reactive human cytotoxic T lymphocytes derived from skin biopsies of delayed-type hypersensitivity reactions induced by injection of an autologous melanoma cell line.
    Waanders GA; Rimoldi D; Liénard D; Carrel S; Lejeune F; Dietrich PY; Cerottini JC; Romero P
    Clin Cancer Res; 1997 May; 3(5):685-96. PubMed ID: 9815737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Active-specific immunotherapy for melanoma.
    Mitchell MS; Harel W; Kempf RA; Hu E; Kan-Mitchell J; Boswell WD; Dean G; Stevenson L
    J Clin Oncol; 1990 May; 8(5):856-69. PubMed ID: 2139701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor-specific cellular immunity.
    Cohen AM; Burdick JF; Ketcham AS
    J Surg Res; 1971 Aug; 11(8):421-31. PubMed ID: 4936302
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.